ROSTISLAV BARABASH: Open Payments
NPI 1699700815 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 67 payments from 14 companies in 2025. Trend: 2023 $848 · 2024 $883 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 17 | $275 |
| ABBVIE INC. | 14 | $173 |
| Tris Pharma Inc | 6 | $95 |
| Janssen Pharmaceuticals, Inc | 5 | $94 |
| Bausch Health US, LLC | 5 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: REXULTI, VRAYLAR, Dyanavel XR, WELLBUTRIN, TRINTELLIX, AUSTEDO XR, SPRAVATO, FANAPT.
Industry payments across NJ — which companies pay providers there.
